Cookson Peirce & Co’s Idexx Laboratories IDXX Stock Holding History

Cookson Peirce & Co’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,034	Closed	-$700K	–	330
2025 Q4	$700K	Buy	+1,034	New	+$704K	0.03%	217

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cookson Peirce & Co's IDXX Position: Q1 2026 in Review

Cookson Peirce & Co sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 1,034 shares — an estimated $700K sold.

Cookson Peirce & Co first reported a position in IDXX in Q4 2025 and held it in 1 quarter. The position peaked at $700K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Cookson Peirce & Co reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Cookson Peirce & Co sold 1,034 Idexx Laboratories shares in Q1 2026, an estimated $700K.
Cookson Peirce & Co first reported a position in Idexx Laboratories in Q4 2025 and held it in 1 quarter.
Cookson Peirce & Co's Idexx Laboratories position peaked at $700K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Cookson Peirce & Co's 13F filing for Q1 2026, filed 30 Apr 2026.